Data / Drug companies / The Magni Company
The Magni Company: 18 products in the FDA NDC directory, labeler code 43689
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
The Magni Company (labeler code 43689) lists 18 products in the FDA National Drug Code Directory, covering 2 finished drugs by generic name. By type: 18 over the counter drugs. Its main marketing category is unapproved homeopathic products. The newest product started marketing on September 25, 2026.
The request: Watch The Magni Company (FDA labeler code 43689): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 43689
- Products in commercial distribution
- 18
- Packages
- 26
- Finished drugs by generic name
- 2
- Prescription products
- 0
- Over the counter products
- 18
- Flagged as original packager
- 15 of 15 products that carry the flag
- Started marketing in the last 12 months
- 8
- Products with a marketing end date set
- 1
- Earliest marketing start
- July 17, 2014
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Unapproved homeopathic products | 17 | 94.4% |
| Over the counter monograph drugs | 1 | 5.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 18 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Graphite, daphne mezereum bark, | 1 | 1 |
| Apis mellifica, gelsemium sempervirens, gnaphalium | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 8 | 44.4% |
| Cream | 7 | 38.9% |
| Liquid | 1 | 5.6% |
| Tablet, orally disintegrating | 1 | 5.6% |
| Spray | 1 | 5.6% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Magnilife Leg and Back Pain Relief | 43689-0067 | Cream | Unapproved homeopathic products | September 25, 2026 |
| Magnilife Relaxing Leg | 43689-0065 | Cream | Unapproved homeopathic products | September 25, 2026 |
| Magnilife Relaxing Leg PM | 43689-0066 | Cream | Unapproved homeopathic products | September 24, 2026 |
| Magnilife Eczema Care | 43689-0035 | Cream | Over the counter monograph drugs | July 9, 2026 |
| Magnilife Pain Relieving Foot | 43689-0063 | Cream | Unapproved homeopathic products | June 29, 2026 |
| Magnilife DB Pain Relieving Foot | 43689-0062 | Cream | Unapproved homeopathic products | June 29, 2026 |
| Magnilife Psoriasis Care | 43689-0036 | Cream | Unapproved homeopathic products | June 29, 2026 |
| DB Foot Pain Relieving | 43689-0070 | Spray | Unapproved homeopathic products | December 1, 2025 |
| Sleep Assist | 43689-0018 | Tablet, orally disintegrating | Unapproved homeopathic products | June 19, 2023 |
| Fibromyalgia Support | 43689-0058 | Tablet | Unapproved homeopathic products | January 25, 2023 |
| Bladder Relief | 43689-0057 | Tablet | Unapproved homeopathic products | March 14, 2022 |
| Muscle Cramp Pain Reliever | 43689-0022 | Tablet | Unapproved homeopathic products | September 18, 2019 |
| Relaxing Legs | 43689-0021 | Liquid | Unapproved homeopathic products | May 9, 2016 |
| Earache Relief | 43689-0020 | Tablet | Unapproved homeopathic products | May 9, 2016 |
| Bladder Relief | 43689-0016 | Tablet | Unapproved homeopathic products | June 12, 2015 |
| Pain and Fatigue Relief | 43689-0015 | Tablet | Unapproved homeopathic products | June 12, 2015 |
| Leg and Back Pain Relief | 43689-0013 | Tablet | Unapproved homeopathic products | June 11, 2015 |
| Migraine Relief | 43689-0017 | Tablet | Unapproved homeopathic products | July 17, 2014 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.